Outlook Therapeutics, Inc. (NASDAQ:OTLK) has a beta value of 0.31 and has seen 1,914,069 shares traded in the recent trading session. The company, currently valued at $143.56 Million, closed the recent trade at $1.26 per share which meant it lost $0 on the day or -3.08% during that session. The OTLK stock price is -129.37% off its 52-week high price of $2.89 and 60.4% above the 52-week low of $0.499. If we look at the company’s 10-day average daily trading volume, we find that it stood at 8.26 Million shares traded. The 3-month trading volume is 2.04 Million shares.

The consensus among analysts is that Outlook Therapeutics, Inc. (OTLK) is a Buy stock at the moment, with a recommendation rating of 1.6. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 5 have rated it as a Hold, with 5 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.11.

Outlook Therapeutics, Inc. (NASDAQ:OTLK) trade information

Despite being -2.69% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the OTLK stock price touched $1.475 or saw a rise of 13.83%. Year-to-date, Outlook Therapeutics, Inc. shares have moved 115.42%, while the 5-day performance has seen it change -6.54%. Over the past 30 days, the shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) have changed 24.61%. Short interest in the company has seen 2.79 Million shares shorted with days to cover at 1.37.

Wall Street analysts have a consensus price target for the stock at $6.05, which means that the shares’ value could jump 380.16% from current levels. The projected low price target is $3.25 while the price target rests at a high of $9. In that case, then, we find that the current price level is +614.29% off the targeted high while a plunge would see the stock lose 157.94% from current levels.

Outlook Therapeutics, Inc. (OTLK) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +22.8% over the past 5 years. Earnings growth for 2020 is a modest +79.7% while over the next 5 years, the company’s earnings are expected to increase by 0%.